JYJianxin Ye

Jianxin Ye

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jianxin Ye has a total of 47 co-authors. Here are the top co-authors by number of shared publications:

  • Tingting Xia

    Department of Gastroenterology, First Affiliated Hospital of Soochow University, Suzhou, 215006, People’s Republic of China

    4 shared publications
  • Yingying Liu

    Department of Gastroenterology, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu 214000, P.R. China

    4 shared publications
  • Chunhui Jin

    Department of Oncology, Wuxi City Hospital of Traditional Chinese Medicine, Wuxi, Jiangsu 214000, P.R. China

    3 shared publications
  • Ke Zhang

    Department of Gastroenterology, Affiliated Changshu Hospital of Nantong University, Changshu, Jiangsu 215500, P.R. China

    3 shared publications
  • Jianhong Zhu

    Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China

    2 shared publications
  • Jikai Zhou

    Department of Gastroenterology, First Affiliated Hospital of Soochow University, Suzhou, 215006, People’s Republic of China

    2 shared publications

Latest Publications

  • Open Access

    The Role and Mechanisms of Tumor-Derived Exosomes in the Formation of the Premetastatic Niche

    by Jichao Wang, Jianxin Ye

    The premetastatic niche is a specialized microenvironment established by tumor cells prior to the formation of metastatic foci in distant organs. This niche provides an optimal landing site for circulating tumor cells. As key mediators of intercellular communication, exosomes play a pivotal role in shaping the premetastatic niche. This review analyzes the effects of exosomes on premetastatic niche formation from multiple perspectives, including angiogenesis, metabolic reprogramming, matrix remodeling, immune response, organicity, and epithelial-mesenchymal transition (EMT). Their value in tumor diagnosis, prognosis, and treatment, as well as the challenges and opportunities for future clinical transformation are discussed. This article presents a narrative review conducted in accordance with the SANRA guidelines.


  • Open Access

    Integrated bioinformatics and experimental validation reveal that CENPF activates mTORC1 signaling to promote colorectal cancer progression

    by Haolin Jiang, Zhaoqiang Chen, Li Zhang, Chenlei Yuan, Shengjia Wang, Jiawei Zhang, Jiaxin Ji, Jin Wang, Zhe Zhang, Yanjin Bai, et al.

    The incidence and mortality rates of colorectal cancer (CRC) continue to increase, underscoring the need to identify key gene networks and clinically relev

  • Open Access

    Biliary Microbial Community and Metabolic Potential in Patients with Multiple Common Bile Duct Stones

    by Tingting Xia, Shuo Feng, Zigui Zou, Jikai Zhou, Xiaodi Cai, Jianxin Ye, Chenguang Dai

    Background: Endoscopic retrograde cholangiopancreatography (ERCP) is widely used in the treatment of choledocholithiasis, while successful extraction of common bile duct stone (CBDS) is commonly hampered by the number of stones. Biliary microbiota has a profound influence on the occurrence of CBDS. In this study, we aimed to investigate the characteristics and metabolic potential of biliary microbiota in patients with multiple CBDS. Methods: Eligible patients were prospectively enrolled in this study at First Affiliated Hospital of Soochow University between December 2022 and October 2023. Bile samples were collected through ERCP. The samples were tested for biliary microbiota and bile acids using 16S rRNA sequencing and ultra-performance liquid chromatography-tandem mass spectrometry, respectively. Metabolic functions were predicted by PICRUSt 2.0 calculation based on MetaCyc database. Results: A total of 31 patients were enrolled, including 17 in multiple stone (MS) group and 14 in single stone (SS) group. Distinct biliary microbial composition was identified in MS group, with a significantly higher abundance of Proteobacteria at phylum level and Enterococcus at genus level, respectively. Klebsiella, Aquabacterium, Morganella and Diaphorobacter were significantly abundant in MS group. Both Morganella and Aeromonas were exclusively found in MS group, along with the absence of Metaprevotella. Chenodeoxycholic acid was significantly enriched in MS group. It was negatively correlated with Enhydrobacter, Massilia and Neglecta that were abundant in SS group. Several metabolic pathways that could increase the risk of CBDS were also enriched in MS group, including L-methionine biosynthesis, aspartate superpathway, glucose and glucose-1-phosphate degradation and superpathway of glycolysis and the Entner-Doudoroff pathway. Conclusion: This study illustrated the microbial structure and metabolic potential of biliary flora in patients with multiple CBDS. The unique biliary microbial community holds the predictive value for clinical conditions. The findings provide new insights about biliary microbiota into the etiology of multiple CBDS.


  • Open Access

    The role of IL‑17, IFN‑γ, 4‑1BBL and tumour‑infiltrating lymphocytes in the occurrence, development and prognosis of pancreatic cancer

    by Yingying Liu, Ke Zhang, Xiaodi Cai, Jikai Zhou, Yixuan Cai, Yujie Gu, Tingting Xia, Jianxin Ye

    Immunotherapy has made progress in the treatment of tumours; however, in patients with pancreatic cancer, immunotherapy has not achieved effective results. The present study investigated changes in the immune microenvironment during tumour development and progression, and the relationship between the immune microenvironment and prognosis, to clarify the mechanism of immune escape in pancreatic cancer. A total of 40 patients with pancreatic cancer (including 22 with stage I‑II disease and 18 with stage III‑IV disease) and 20 patients with chronic pancreatitis were included in the present study. The expression of CD3, CD4, CD8, CD56, IFN‑γ, IL‑17 and 4‑1BBL was assessed by immunohistochemistry, and the mRNA expression levels were detected by reverse transcription‑quantitative PCR (RT‑qPCR). The clinicopathological characteristics and prognoses of patients with pancreatic cancer were analysed to further explore the role of IL‑17, IFN‑γ, 4‑1BBL and tumour‑infiltrating lymphocytes in pancreatic cancer. Notably, the expression levels of CD3, CD8, CD56, IFN‑γ and 4‑1BBL in patients with stages I‑II and III‑IV cancer were lower than those in patients with chronic pancreatitis (P<0.05), especially in patients with stage III‑IV cancer (P<0.05). In addition, the expression of IL‑17 in patients with stages I‑II and III‑IV cancer was greater than in patients with chronic pancreatitis (P<0.05), especially in patients with stage III‑IV cancer (P<0.05). The RT‑qPCR results regarding CD3, CD4, CD8, CD56, IFN‑γ and IL‑17 were almost the same as those obtained from immunohistochemical analysis; however, the mRNA expression levels of 4‑1BBL were not significantly different between stages I‑II and III‑IV. Furthermore, patients with pancreatic cancer with higher expression levels of CD3, CD8, CD56, IFN‑γ and 4‑1BBL exhibited longer survival, whereas those with higher expression of IL‑17 had a shorter survival time. The expression levels of CD3, CD8, CD56, cytokines IL‑17 and IFN‑γ, and costimulatory molecule 4‑1BBL were revealed to be related to the degree of differentiation, Tumour‑Node‑Metastasis staging and the prognosis of pancreatic cancer, and may serve as novel immunological indicators for evaluating the condition and treatment effectiveness in patients with pancreatic cancer.


  • Open Access

    Characteristics and metabolic potential of biliary microbiota in patients with giant common bile duct stones

    by Chenguang Dai, Chunfang Xu, Lu Zheng, Min Wang, Zhining Fan, Jianxin Ye, Dongming Su

    Background: Endoscopic retrograde cholangiopancreatography (ERCP) is an effective minimally invasive operation for the management of choledocholithiasis, while successful extraction is hampered by large diameter of stones. Emerging studies have revealed the close correlation between biliary microbiota and common bile duct stones (CBDS). In this study, we aimed to investigate the community characteristics and metabolic functions of biliary microbiota in patients with giant CBDS.Methods: Eligible patients were prospectively enrolled in this study in First Affiliated Hospital of Soochow University from February 2022 to October 2022. Bile samples were collected through ERCP. The microbiota was analyzed using 16S rRNA sequencing. Metabolic functions were predicted by PICRUSTs 2.0 calculation based on MetaCyc database. Bile acids were tested and identified using ultra performance liquid chromatography-tandem mass spectrometry.Results: A total of 26 patients were successfully included into final analysis, 8 in giant stone (GS) group and 18 in control group. Distinct biliary microbial composition was identified in patients with giant CBDS, with a significantly higher abundance of Firmicutes at phylum level. The unique composition at genus level mainly consisted of Enterococcus, Citrobacter, Lactobacillus, Pyramidobacter, Bifidobacterium and Shewanella. Pyramidobacter was exclusively found in GS group, along with the absence of Robinsoniella and Coprococcus. The contents of free bile acids were significantly higher in GS group, including cholic acid (98.39μmol/mL vs. 26.15μmol/mL, p=0.035), chenodesoxycholic acid (54.69μmol/mL vs. 5.86μmol/mL, p=0.022) and ursodeoxycholic acid (2.70μmol/mL vs. 0.17μmol/mL, p=0.047). Decreasing tendency of conjugated bile acids were also observed. Metabolic pathways concerning cholelithiasis were abundant in GS group, including geranylgeranyl diphosphate biosynthesis, gluconeogenesis, glycolysis and L-methionine biosynthesis.Conclusions: This study demonstrated the community structure and metabolic potential of biliary microbiota in patients with giant CBDS. The unique biliary microbial composition holds valuable predictive potential for clinical conditions. These findings provide new insights into the etiology of giant CBDS from the perspective of biliary microbiota.


  • T cell immunity induced by a bivalent Salmonella-based CEACAM6 and 4-1BBL vaccines in a rat colorectal cancer model

    by Chunhui Jin, Xiaoqing Duan, Yingying Liu, Jianhong Zhu, Ke Zhang, Yuanting Zhang, Tingting Xia, Yajun Fei, Jianxin Ye

    The present study investigated the anti‑tumor mechanisms of recombinant non‑specific cross‑reacting antigen (CEACAM6) and 4‑1BB ligand (4‑1BBL) Salmonella‑based vaccines, and the effect that these vaccinations have on memory T cells and T helper (Th) cell polarization. Colon tumors were induced in rats via 1,2‑dimethylhydrazine (DMH) injections. Rats were then treated with injections of attenuated Salmonella typhimurium carrying pIRES‑CEACAM6, pIRES‑4‑1BBL or pIRES‑CEACAM6‑4‑1BBL. In total, 4 vaccine injections, one every other week, were administered during the 8 weeks subsequent to the DMH injection. Rats were sacrificed 18 weeks subsequent to the DMH injections, and the colons and spleens were collected for further analysis. Cluster of differentiation (CD) 45RO, interleukin (IL)‑4 and IL‑17 expression was analyzed in colon tumor tissues, and the expression of interferon (IFN)‑γ, CD3+, CD4+, CD8+, CD56+, forkhead/winged‑helix transcription factor box P3 (FOXP3+), IL‑4 and IL‑17 were analyzed in splenic tissues. Compared with the pIRES/SL3261 group, the pIRES‑CEACAM6‑4‑1BBL/SL3261 treatment group had a significantly higher number of CD45RO+ expressing tumor infiltrating lymphocytes and lower expression levels of IL‑4 and IL‑17. Splenic tissues from the same treatment group exhibited significantly increased expression of IFN‑γ, CD3+ and CD8+ and reduced expression levels of Foxp3, IL‑4 and IL‑7. CD56+ T cell expression was increased in all groups except for the group that received no vaccine. The present study concluded that the combined CEACAM6 and 4‑1BBL‑attenuated recombinant Salmonella vaccine was able to inhibit the growth of DMH‑induced colorectal tumors. This was mediated by generating an anti‑tumor immune response, increasing the number of of CD45RO+ memory T cells, decreasing the number of FOXP3+ cells and promoting Th1 polarization.


  • Open Access

    FOXP3 and CEACAM6 expression and T cell infiltration in the occurrence and development of colon cancer

    by Yingying Liu, Tingting Xia, Chunhui Jin, Dongmei Gu, Jie Yu, Weiqiang Shi, Ke Zhang, Liping Zhang, Jianxin Ye, Ling Li

    The transcription factor forkhead box P3 (FOXP3) is involved in immune cell regulation, and carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) is an adhesion molecule of the immunoglobulin superfamily. These two genes are associated with cancer progression. In the current study, colon tissue specimens from 78 cases of colon cancer (including 40 of stage I–II and 38 of stage III–IV), 30 cases of colonic adenoma and 12 healthy controls were collected from the First Affiliated Hospital of Soochow University between January 2010 and December 2011. The expression of cluster of differentiation (CD) 3, CD4, CD8, CD45RO, CEACAM6 and FOXP3 in colon tissues was examined by immunohistochemical analysis. In addition, a reverse transcription-quantitative polymerase chain reaction (RT-qPCR) assay, based on SYBR Green I, was used to detect CD3, CD4, CD8, CD45RO, CEACAM6 and FOXP3 mRNA levels in the paraffin block specimens. CD3+, CD8+ and CD45RO+ T cell infiltrations in colonic adenoma were significantly higher than in normal colonic mucosa (P<0.001, P=0.001 and P<0.001, respectively). However, CD3+, CD8+ and CD45RO+ lymphocytes in stage III–IV colon cancer tissues were lower than in normal control tissues (P=0.015, P=0.002 and P=0.041, respectively); consistently, CD3+, CD4+, CD8+ and CD45RO+ lymphocytes in stage III–IV tissues were even more markedly lower compared with adenoma (P=0.001, P<0.001, P<0.001 and P<0.001, respectively). Similarly, CD3+, CD8+ and CD45RO+ T cell infiltration was lower in stage I–II cancer tissues compared with adenoma (P=0.001, P<0.001 and P<0.001). CD3+, CD4+, CD8+ and CD45RO+ T cell infiltrations were also significantly higher in stage I–II compared with stage III–IV cancer tissues (P<0.001, P=0.045, P<0.001 and P<0.001, respectively). CEACAM6 was found to gradually increase from normal colon tissue to adenoma and cancer tissue. FOXP3 was expressed more highly in stage I–II compared with normal tissues (P=0.014), and was even higher in stage III–IV (P<0.001). These results were verified using RT-qPCR, which yielded almost identical results. In summary, the current study demonstrates that FOXP3, CEACAM6 and T cell infiltration are significantly associated with the occurrence and progression of colon cancer, and that immune reactions vary between different stages of colon cancer development.


  • Recombinant Salmonella-based CEACAM6 and 4-1BBL vaccine enhances T-cell immunity and inhibits the development of colorectal cancer in rats: in vivo effects of vaccine containing 4-1BBL and CEACAM6

    by Chunhui Jin, Yingying Liu, Jianhong Zhu, Tingting Xia, Baonan Zhang, Yajun Fei, Bo Ma, Jianxin Ye, Weichang Chen

    The present study aimed to determine the effect of recombinant Salmonella (SL3261)-based CEACAM6 and 4-1BB ligand (4-1BBL) vaccine on the development of colorectal cancer in rats and the potential immune mechanisms involved. Attenuated Salmonella typhimurium (vaccine strain)‑carrying plasmids pIRES-CEACAM6, pIRES‑4‑1BBL and pIRES-CEACAM6-4-1BBL were constructed. The rats were administered subcutaneous injections of 1,2-dimethyl-hydrazine (DMH) once a week for 18 weeks. Eight weeks after the first injection, the rats were divided into the pIRES/SL3261, pIRES-4-1BBL/SL3261, pIRES-CEACAM6/SL3261 and pIRES-CEACAM6-4-1BBL/SL3261 groups, and fed with corresponding vaccine strains. The rats were then sacrificed, the number of colon tumors were recorded, and the Dukes' stage were evaluated. CD3, CD4, CD8, CD56, FOXP3 and CEACAM6 expression in tumor tissues was determined by immunohistochemical staining. Compared with the expression levels in the pIRES/SL3261 group, similar levels of CD3+, CD8+ and CD56+ expression were identified for the pIRES-CEACAM6/SL3261 group of rats. Additionally, a comparable number of tumors was detected in the pIRES-4-1BBL/SL3261 and pIRES-CEACAM6/SL3261 groups. By contrast, a significantly fewer number of tumors, albeit with a higher density of CD3+CD8+, CD56+ and a lower density of Foxp3+ tumor-infiltrating lymphocyte (TIL) cells was detected in the pIRES-CEACAM6-4-1BBL/SL3261 group of rats. The results indicated that vaccination with recombinant attenuated Salmonella harboring the CEACAM6 and 4-1BBL gene efficiently increased the number of CD3+CD8+ TIL and NK cells, decreased the number of FOXP3 cells and inhibited the development of DMH-induced colorectal cancer in rats.


  • Open Access

    Recombinant salmonella-based 4-1BBL vaccine enhances T cell immunity and inhibits the development of colorectal cancer in rats: in vivo effects of vaccine containing 4-1BBL

    by Jianxin Ye, Ling Li, Yuanting Zhang, Xueguang Zhang, Daming Ren, Weichang Chen

    Background: Immunotherapy with vaccines is attractive for the treatment of cancer. This study is aimed at determining the effect of recombinant Salmonella (SL3261)-based 4-1BB ligand (4-1BBL) vaccine on the development of colorectal cancers and the potential immune mechanisms in rats. Results: In comparison with that in the PBS group, similar levels of 4-1BBL expression, the frequency of T cells, IFN-γ responses, and comparable numbers of tumors were detected in the SL3261 and SL3261C groups of rats. In contrast, significantly fewer numbers of tumors, increased levels of 4-1BBL expression in the spleens and colorectal tissues, higher frequency of peripheral blood and splenic CD3+CD25+ T cells, and stronger splenic T cell IFN-γ responses were detected in the SL3261R group of rats. Conclusion: Our results indicated that vaccination with recombinant attenuated Salmonella harboring the 4-1BBL gene efficiently enhanced T cell immunity and inhibited the development of carcinogen-induced colorectal cancers in rats.